Article
Incidence of Guillain-Barré syndrome following SARS-CoV-2 immunization in Mexico: A nation-wide registry of seven COVID-19 vaccines
2022-04-12
Abstract excerpt
<h4>Summary</h4> <h4>Background</h4> Guillain-Barré syndrome (GBS) as an adverse event following immunization (AEFI) against SARS-CoV-2 has been linked to a few (ChAdOx1 nCov-19 and Ad26.COV2-S), but not all vaccines, including mRNA-based ones. Epidemiological information on GBS among recipients of other SARS-CoV-2-directed vaccines among Latinx/Hispanic recipients is scarce. <h4>Methods</h4> We report GBS inciden...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- f598fe55-5555-5b5d-958c-57f01e39aa12
- DOI
- 10.1101/2022.04.11.22273754
